Skip to main content
OpenTrials
Completed

NCT Number: NCT00648687

Pain Response During Examination for Retinopathy of Prematurity

Newborns infants equal or less than 1500 grams and/or equal and less than 32 weeks will have ophthalmologic examination for ROP at 6 weeks old. They will be randomized blindly to receive 2 ml of 12.5% dextrose in water (D12.5W) orally five minute before examination (intervention group) or nothing (control). NIPS scale will be applied two minutes before examination and two minutes after examination.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • all newborns equal or less than 1500 grams birth weight and/or equal or less than 32 weeks gestational age

Exclusion criteria

  • the ones that died before 6 weeks old

Treatment and study plan

suck 12.5% dextrose in water 5 minutes before the procedure

Behavioral

Newborns will suck 2 ml of D12.5W 5 minutes before eye exam for ROP

Primary outcomes

  1. Pain secondary to eye examination

    Time frame: 2 minutes after the exam

Sponsors and collaborators

Lead sponsor

National Bioethics Commission of Brazil

Other

Registry information

Official study title

Evaluation of the Pain Response During Examination for Retinopathy of Prematurity in Very Low Birth Weight Infants

Acronym: ROP

Important dates

Study start
2008
Primary completion
2010
Study completion
2010
First posted
Apr 1, 2008
Registry last updated
Jul 22, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.